Back

Regression of microalbuminuria predicts cardiovascular risk reduction with GLP-1 receptor agonist therapy

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic pharmacotherapy and cardiovascular outcomes Antidiabetic Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ivan Rafael Figueroa Baez

San Juan City Hospital, San Juan (Puerto Rico)

5 More presentations in this session

Presentation thumbnail
B-type natriuretic peptide level reduction and its predictors following sodium-glucose cotransporter 2 inhibitor treatment in patients with diabetic kidney disease
Doctor T. Nagahiro (Yokohama, JP)
Abstract
Presentation thumbnail
Cardiovascular and renal outcomes of Semaglutide in patients with Type 2 Diabetes Mellitus with established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease: A Meta-Analysis
Doctor F. Lumancas (Cebu City, PH)
Abstract
Presentation thumbnail
Impact of semaglutide on mortality, cardiovascular, and kidney outcomes across the cardio-kidney-metabolic continuum: a meta-analysis of randomized controlled trials
Doctor C. Cotticelli (Naples, IT)
Abstract
Presentation thumbnail
Effects of luseogliflozin on sympathetic nerve activity:a dual assessment using iodine-123-metaiodobenzylguanidine and muscle sympathetic nerve activity
Mr T. Hirai (Kanazawa, JP)
Abstract
Presentation thumbnail
Comparative cardiovascular efficacy of individual GLP-1 receptor agonists and tirzepatide: a Bayesian network meta-analysis of 13 cardiovascular outcome trials
Ms Y. Srivastava (IN)
Abstract

Access the full session

Session thumbnail
Cardiometabolic pharmacotherapy and cardiovascular outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus: insights from the EMPA-REG OUTCOME trial
29 June 2021
thumbnail
Congress Presentation
Exploring the preventive role of GLP-1 receptor agonists in reducing pulmonary hypertension in diabetes: a multimodal analysis
3 April 2025
thumbnail
Congress Presentation
Microalbuminuria as an independent predictor of long-term mortality in diabetic and non-diabetic patients with acute coronary syndromes
29 August 2025
thumbnail
Congress Presentation
Does dulaglutide impact a composite outcome reflecting atherosclerosis? A post-hoc analysis of the REWIND trial
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources